Kenvue Inc (NYSE:KVUE)
$ 19.75 +0.27 (+1.39%) Market Cap: 37.92 Bil Enterprise Value: 45.65 Bil PE Ratio: 23.24 PB Ratio: 3.57 GF Score: 70/100

Q4 2024 Kenvue Inc Earnings Call Transcript

Feb 06, 2025 / 01:00PM GMT
Release Date Price: $19.8 (-4.53%)

Key Points

Positve
  • Kenvue Inc (KVUE) expanded its adjusted gross margin by 200 basis points year over year to 60.4%, driven by strong productivity enhancements.
  • The company successfully executed the first year of its 'Vue Forward' initiative, aiming for $350 million in annualized savings by 2026.
  • Kenvue Inc (KVUE) increased its total brand investment by about 20%, focusing on advertising, social media influencer-led campaigns, and healthcare professional engagement.
  • The Skin Health and Beauty segment showed volume-led organic sales growth, particularly strong in EMEA and Latin America.
  • Kenvue Inc (KVUE) is launching 40% more innovation in 2025 compared to 2024, aiming to strengthen its portfolio through premiumization and extension into adjacencies.
Negative
  • Organic sales growth for 2024 was 1.5%, below expectations, partly due to lower incidences of cough, cold, and flu, impacting the pediatric pain franchise.
  • The company faced a reduction in distributor orders in Asia Pacific, particularly in China, due to temporary distribution network disruptions.
  • Fourth-quarter organic sales growth was only 1.7%, falling short of expectations due to weak December sales.
  • Kenvue Inc (KVUE) anticipates a challenging external environment in 2025, with economic uncertainty, geopolitical tensions, and a stronger dollar.
  • The company expects a three- to four-point headwind in the first quarter of 2025 due to destocking and strategic price investments.
Operator

Hello, and welcome to the Kenvue fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Sofya Tsinis, Head of Investor Relations for Kenvue.

Sofya Tsinis
Kenvue Inc - Head, Investor Relations

Good morning, everyone, and welcome to Kenvue's fourth-quarter and full-year 2024 earnings conference call. I'm pleased to be joined today by Thibaut Mongon, Chief Executive Officer; and Paul Ruh, Chief Financial Officer.

Before we get started, I'd like to remind you that today's call includes forward-looking statements regarding, among other things, our operating and financial performance, market opportunities, and growth. These statements represent our current beliefs, expectations or assumptions about future events and are subject to various risks, uncertainties, and changes that are difficult to predict, and could cause our actual results to differ materially. For information regarding these risks and uncertainties, please

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot